[go: up one dir, main page]

DE69534733D1 - NEUARTIGE AUF p53 ANSPRECHENDE GENE - Google Patents

NEUARTIGE AUF p53 ANSPRECHENDE GENE

Info

Publication number
DE69534733D1
DE69534733D1 DE69534733T DE69534733T DE69534733D1 DE 69534733 D1 DE69534733 D1 DE 69534733D1 DE 69534733 T DE69534733 T DE 69534733T DE 69534733 T DE69534733 T DE 69534733T DE 69534733 D1 DE69534733 D1 DE 69534733D1
Authority
DE
Germany
Prior art keywords
new
responsive genes
pigi
expression vectors
polypeptide molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69534733T
Other languages
English (en)
Other versions
DE69534733T2 (de
Inventor
Leonard Buckbinder
Randy Talbott
Bernd R Seizinger
Nikolai Kley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DE69534733D1 publication Critical patent/DE69534733D1/de
Publication of DE69534733T2 publication Critical patent/DE69534733T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69534733T 1994-07-12 1995-07-10 NEUARTIGE AUF p53 ANSPRECHENDE GENE Expired - Lifetime DE69534733T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/274,318 US5667987A (en) 1994-07-12 1994-07-12 P53 response genes
US274318 1994-07-12
PCT/US1995/008597 WO1996001907A1 (en) 1994-07-12 1995-07-10 NOVEL p53 RESPONSE GENES

Publications (2)

Publication Number Publication Date
DE69534733D1 true DE69534733D1 (de) 2006-03-30
DE69534733T2 DE69534733T2 (de) 2006-09-14

Family

ID=23047698

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69534733T Expired - Lifetime DE69534733T2 (de) 1994-07-12 1995-07-10 NEUARTIGE AUF p53 ANSPRECHENDE GENE

Country Status (6)

Country Link
US (2) US5667987A (de)
EP (1) EP0804609B1 (de)
AT (1) ATE315087T1 (de)
DE (1) DE69534733T2 (de)
ES (1) ES2256847T3 (de)
WO (1) WO1996001907A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020155A (en) * 1991-11-20 2000-02-01 Trustees Of Dartmouth College Nucleic acids encoding CR1 fusion protein, vector, transfected cell and expression
US5969120A (en) * 1993-09-03 1999-10-19 Research Development Foundation Mutants of the RB and P53 genes
US5670325A (en) * 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
CA2256498A1 (en) * 1996-05-29 1997-12-04 Genzyme Corporation Cell growth regulatory genes
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6100029A (en) * 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US6020137A (en) * 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US6146828A (en) * 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US5952178A (en) 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
US6134148A (en) * 1997-09-30 2000-10-17 Hitachi, Ltd. Semiconductor integrated circuit and data processing system
JP3930074B2 (ja) * 1996-09-30 2007-06-13 株式会社ルネサステクノロジ 半導体集積回路及びデータ処理システム
US6020142A (en) * 1996-10-04 2000-02-01 Millennium Pharmaceuticals, Inc. Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders
US5846780A (en) * 1996-10-04 1998-12-08 Millennium Pharmaceuticals, Inc. Murine RATH gene
US6048693A (en) * 1996-10-16 2000-04-11 Bittech, Inc. Phenotypic assays of cyclin/cyclin-dependent kinase function
AU4903897A (en) * 1996-10-16 1998-05-11 Bittech, Inc. Phenotypic assays of cyclin/cyclin-dependent kinase function
KR100497800B1 (ko) * 1996-11-06 2005-11-24 미쯔이가가꾸가부시끼가이샤 α-올레핀 중합반응을 위한 공정, 이에 의해 제조한 폴리-α-올레핀, 및 이 공정을 위한 촉매 성분으로서 유용한 아미노실란화합물
US5858715A (en) * 1997-01-29 1999-01-12 Incyte Pharmaceuticals, Inc. Human apoptosis-associated protein
DE19736691A1 (de) * 1997-08-22 1999-02-25 Michael Prof Dr Med Giesing Verfahren zur Charakterisierung und Identifizierung disseminierter und metastasierter Krebszellen
WO1999025820A1 (en) * 1997-11-17 1999-05-27 Warner-Lambert Company p53CP, A PROTEIN THAT SPECIFICALLY BINDS TO CONSENSUS p53 DNA BINDING SITES
US6020135A (en) * 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
US7691370B2 (en) * 1998-10-15 2010-04-06 Canji, Inc. Selectivity replicating viral vector
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
DE60029092T2 (de) 1999-04-09 2007-02-01 Exact Sciences Corp., Marlborough Verfahren zur detektion von nukleinsäuren, welche auf krebs hinweisen
US6849403B1 (en) 1999-09-08 2005-02-01 Exact Sciences Corporation Apparatus and method for drug screening
US6864355B1 (en) 2000-05-02 2005-03-08 Yale University Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
AU4714201A (en) 1999-12-07 2001-06-18 Exact Sciences Corporation Supracolonic aerodigestive neoplasm detection
US6919174B1 (en) 1999-12-07 2005-07-19 Exact Sciences Corporation Methods for disease detection
US7229096B2 (en) * 2004-05-06 2007-06-12 Delphi Technologies, Inc. Adaptive energy absorbing system using pin pullers
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
WO2007044071A2 (en) 2005-04-21 2007-04-19 Exact Sciences Corporation Analysis of heterogeneous nucleic acid samples

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314995A (en) * 1990-01-22 1994-05-24 Oncogen Therapeutic interleukin-2-antibody based fusion proteins
WO1993010230A1 (en) * 1991-11-20 1993-05-27 Trustees Of Dartmouth College Ligand-stimulated gene expression

Also Published As

Publication number Publication date
EP0804609A4 (de) 1998-01-21
US5886149A (en) 1999-03-23
DE69534733T2 (de) 2006-09-14
EP0804609B1 (de) 2006-01-04
US5667987A (en) 1997-09-16
ES2256847T3 (es) 2006-07-16
EP0804609A1 (de) 1997-11-05
ATE315087T1 (de) 2006-02-15
WO1996001907A1 (en) 1996-01-25

Similar Documents

Publication Publication Date Title
DE69534733D1 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
FR19C1020I1 (fr) Nouvelles molecules b7-4 et leurs utilisations
ES2177475T1 (es) Genes de corynebacterium glutamicum que codifican proteinas de una ruta metabolica.
DE69636866D1 (en) Reverse "two-hybrid"-systeme
DK0941318T5 (da) Håndvægtformede konstruerede ekspressionssystemer til genterapi
DE69635207D1 (de) Auf Chromosom 1 lokalisiertes Gen dessen Genprodukt mit der Alzheimerschen Krankheit assoziiert ist.
DK1218504T3 (da) GL50 molekyler og anvendelser deraf
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
ATE459712T1 (de) Transskriptionsaktivatoren mit stufenweisen transaktivierendem potential
CA2091102A1 (en) Microsomal triglyceride transfer protein
DE60045191D1 (de) Corynebacterium glutamicum gene, die für stoffwechselproteine kodieren
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
WO2000019988A8 (en) NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
HUP9900750A2 (hu) Gén kifejezésére szolgáló promóterek
DK0877758T3 (da) Oprenset SR-p70-protein
DE59712554D1 (de) Rekombinante expression von s-layer-proteinen
WO2002034896A3 (en) 13245, a novel human myotonic dystrophy type protein kinase and uses therefor
BR9810643A (pt) Genes e proteìnas de telomerase de vertebrado, eutilização dos mesmos

Legal Events

Date Code Title Description
8364 No opposition during term of opposition